Liver dysfunction risk may also be increased when medicinal products that are inhibitors of the bile salt export pump (BSEP), e. g., rifampicin, glibenclamide and cyclosporine A (see sections 4.3 and 4.5), are co- administered with bosentan, but limited data are available.
4. 3 og 4. 5) samtidigt med bosentan, men der er kun begrænsede data herom til rådighed.